Clinical Trial Update: A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge [Phase 1]

View source ↗

Summary

This Phase 1 study compares the blood levels of Mim8 in healthy men when administered using the DV3407-C1 Pen Injector versus a syringe and cartridge.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• MIM8

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A | Phase 1 | Status: COMPLETED